Endoscopic Multifunctional Optical Coherence Tomography for Airway Tissue Injury Management

Information

  • Research Project
  • 10081106
  • ApplicationId
    10081106
  • Core Project Number
    R43HL154866
  • Full Project Number
    1R43HL154866-01
  • Serial Number
    154866
  • FOA Number
    PA-19-272
  • Sub Project Id
  • Project Start Date
    9/1/2020 - 5 years ago
  • Project End Date
    8/31/2021 - 4 years ago
  • Program Officer Name
    FESSEL, JOSHUA P
  • Budget Start Date
    9/1/2020 - 5 years ago
  • Budget End Date
    8/31/2021 - 4 years ago
  • Fiscal Year
    2020
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/24/2020 - 5 years ago
Organizations

Endoscopic Multifunctional Optical Coherence Tomography for Airway Tissue Injury Management

Project Summary/Abstract Inhalation injury is an important cause of morbidity and mortality in the civilian population. It is usually caused by the inhalation of smoke or toxic gases, such as carbon monoxide, hydrogen cyanide, nitrogen dioxide, etc. Bronchoscopy is currently used as a standard approach for inhalation injury assessment. However, it fails to provide submucosal and functional tissue information, both of which are essential for proper triage and selection of appropriate therapy. Physical Sciences Inc., in collaboration with the University of North Carolina, Chapel Hill, proposes to develop a novel Endoscopic Multifunctional Optical Coherence Tomography instrument for Airway Tissue Injury Management that will provide clinicians with real-time feedback regarding the morphological and functional changes of the injured tissue. This instrument will complement qualitative bronchoscopic findings with quantitative submucosal morphological and functional information, such as ciliary activity and compliance, which will enable more efficient screening, triage, and therapeutic guidance of inhalation exposures. The goal of the Phase I program is to demonstrate the feasibility of the proposed technology for airway inhalation injury assessment, while in Phase II an advanced clinical instrument will be proposed to be developed and preliminarily tested on human patients of acute inhalation injury.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    258631
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    838
  • Ed Inst. Type
  • Funding ICs
    NHLBI:258631\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PHYSICAL SCIENCES, INC
  • Organization Department
  • Organization DUNS
    073800062
  • Organization City
    ANDOVER
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    018101022
  • Organization District
    UNITED STATES